Jiang W, Chen H, Gao J, Huaibei M
Occupational Hospital for Treatment and Prevention, Huaibei, Anhui 235000.
Zhonghua Jie He He Hu Xi Za Zhi. 1998 Nov;21(11):648-50.
To evaluate the short and long-term effects of regimens containing INH, RFP with varied chemotherapy courses on culture-positive pneumoconio-tuberculosis.
79 patients with culture-positive pneumoconio-tuberculosis were divided into three groups according to chemotherapy duration: 9-months group (M9: 2SHRZ/7HRE) 28 cases, 12-month group (2SHRZ/10HRE) 25 cases, 18-month group (M18: 2SHRZ/10HRE/6HR) 26 cases. Evaluating the efficacy of regimens depended predominantly on sputum bacteriological conversion, and the patients who completed the regimens were followed up for 5-8 years.
Sputum negative conversion rates of three groups at the end of chemotherapy were 83%, 96%, 95%, and their recurrent rates in follow-up period 41%, 4% and 5% respectively. Of all patients who completed the regimens bacteriological relapse rates from the first to fourth year are 6%, 8%, 2%, 2% in the follow-up period. There was no bacteriological relapse from fifth to eighth year.
It is effective for SHRZ/HRE combination with 12-months course to retreated tubercle bacillus positive pneumoconio-tuberculosis, and it is appropriate for such patients to be followed up for 4-5 years.
评估含异烟肼(INH)、利福平(RFP)且化疗疗程不同的方案对痰菌阳性尘肺结核的短期和长期疗效。
79例痰菌阳性尘肺结核患者按化疗疗程分为三组:9个月疗程组(M9:2SHRZ/7HRE)28例,12个月疗程组(2SHRZ/10HRE)25例,18个月疗程组(M18:2SHRZ/10HRE/6HR)26例。主要依据痰菌转阴情况评估方案疗效,对完成疗程的患者进行5 - 8年随访。
三组化疗结束时痰菌阴转率分别为83%、96%、95%,随访期复发率分别为41%、4%、5%。完成疗程的所有患者随访期内第1至4年细菌学复发率分别为6%、8%、2%、2%,第5至8年无细菌学复发。
SHRZ/HRE组合12个月疗程对复治痰菌阳性尘肺结核有效,此类患者随访4 - 5年为宜。